Bibliografía
1. Preda C, Fulger LE, Gheorghe L, Gheorghe C, Goldis A, Trifan A and et al. Infliximab and Adalimumab in Crohn’s disease: real- life data from a national cohort study. Current Health Sciences Journal 2016;42 (2):115-124.
2. Preda CM, Fulger LE, Negreanu L, Manuc M, Sandra I, Diculescu M. Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study.RevEspEnferm Dig 2016;108(10):642-647.
3. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
4. Manuc TE, Manuc MM, Diculescu MM. Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets. Clin Exp Gastroenterol 2016;9:59-70. doi: 10.2147/CEG.S53381
5. Frolkis A, Dieleman LA, Barkema HW, Panaccione R, Ghosh S, Fedorak RN et al. Environment and the inflammatory bowel diseases. Can J gastroenterol 2013;27(3):18-24.
6. Latour P, Louis E, Belaiche J.Incidence of inflammatory bowel disease in the area of Liège: a 3 years prospective study (1993-1996). Acta Gastroenterol Belg. 1998 ;61(4):410-3.
7. Gheorghe C, Pascu O, Gheorghe L et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol. 2004;16(11):1153-9.
8. Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D and et al. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study. J Crohns Colitis 2014;8(7):607-16. doi: 10.1016/j.crohns.2013.11.021. Epub 2013 Dec 7
9. Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Ramirez VH et al. European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD. J Crohns Colitis 2017;11(8):905-920. doi: 10.1093/ecco-jcc/jjw223.
10. Cnmrmc.insp.gov.ro/images/rapoarte/starea-de-nutritie.pdf
11. Abramson, J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov. 2011; 8(1):1.
12. Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016;7(1):112-25. doi: 10.4292/wjgpt.v7.i1.112.
13. Hansen TS, Jess T, Vind I, Elkjaer M, Nielsen MF, Gamborg M et al. Environmental factors in inflammatory bowel disease: A case-control study based on a Danish inception cohort. Journal of Crohn's and Colitis 2011;5(6):577–584 https://doi.org/10.1016/j.crohns.2011.05.010
14. Ye Y, Pang Z, Chen W, Ju S, Zhou C. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med2015; 8(12): 22529–22542.
15. Amarapurkar AD, Amarapurkar DN, Rathi P, Sawant P, Patel N, Kamani P and et al. Risk factors for inflammatory bowel disease: A prospective multi-center study. Indian J Gastroenterol 2018;37(3):189-195. doi: 10.1007/s12664-018-0850-0.
16. Niewiadomski O, Studd C, Wilson J, Williams J, Hair C, Knight R et al. Influence of food and lifestyle on the risk of developing inflammatory bowel disease. Intern Med J 2016; 46(6):669-76. doi: 10.1111/imj.13094.
17. Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease -- a population based study 2007-2009. J Crohns Colitis 2013;7(1):79-88. doi: 10.1016/j.crohns.2012.05.024. Epub 2012 Jun 29
18. Rogler G, Zeitz J, Biedermann L. The search for causative environmental factors in inflammatory bowel disease. Digestive Diseases 2016;34(1):48-55. doi: https://doi.org/10.1159/000447283
19. Andersen V, Chan S, Luben R, Khaw K-T, Olsen A, Tjonneland A et al. Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD). Journal of Crohn's and Colitis 2018;12(2):129–136. doi:10.1093/ecco-jcc/jjx136
20. Shadnoush M, Shaker Hosseini R, Mehrabi Y, Delpisheh A, Alipoor E, Faghfoori Z et al. Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease. Iran J Pharm Res2013;12(4):929-36.
21. Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Korean J Gastroenterol2015; 65(4):215-21. doi: 10.4166/kjg.2015.65.4.215.
22. Baroja ML,Kirjavainen PV,Hekmat S, ReidG.Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. ClinExpImmunol2007;149(3):470–479. doi: 10.1111/j.1365-2249.2007.03434.x
23. Cohen AB, Lee D, Long MD, Kappelman MD, Martin CF, Sandler RS et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 2013;58(5):1322-8. doi: 10.1007/s10620-012-2373-3.
24. Maconi G, Ardizzone S, Cucino C, Bezzio C, Russo AG, Bianchi Porro G. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: A case-control study. World J Gastroenterol2010;16(34):4297-4304 doi: http://dx.doi.org/10.3748/wjg.v16.i34.4297
25. Opstelten JL, Leenders M, Dik VK, Chan SS, van Schaik FD, Khaw KT et al. Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation. Inflamm Bowel Dis2016;22(6):1403-11. doi: 10.1097/MIB.0000000000000798.
26. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012;160:29-44 doi: 10.1016/j.trsl.2011.09.001
27. Ge J, Han TJ, Liu J, Li JS, Zhang XH, Wang Y et al. Meat intake and risk of inflammatory bowel disease: A meta-analysis. Turk JGastroenterol 2015;26(6):492-7. doi: 10.5152/tjg.2015.0106.
28. Limdi JK. Dietary practices and inflammatory bowel disease.Indian J Gastroenterol2018;37(4):284–292.doi: 10.1007/s12664-018-0890-5
29. Burke KE, Boumitri C,Ananthakrishnan AN. Modifiable environmental factors in inflammatory bowel disease. CurrGastroenterol Rep 2017; 19(5):21. doi:10.1007/s11894-017-0562-0.
30. Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol2016; 22(27):6296-6317 doi: http://dx.doi.org/10.3748/wjg.v22. i27.6296
31. Chassaing B, De Bodt J, Marzorati M, Van de Wiele T, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut 2017;66(8):1414–1427. doi:10.1136/gutjnl-2016-313099.
32. Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol2016; 22(3):895-905. doi: http://dx.doi.org/10.3748/wjg.v22.i3.895
33. Racine A, Carbonnel F, Chan SS, Hart AR, Bueno-de-Mesquita HB, Oldenburg Band et al.Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis 2016;22(2):345-54. doi: 10.1097/MIB.0000000000000638.
34. Jin ZQ, Lu HG, Wu QB, Ge HX, Zhou TT, Zhang XQ et al. A meta-analysis of dietary carbohydrate intake and inflammatory bowel disease risk: evidence from 15 epidemiology studies. Rev Esp Enferm Dig. 2019;111(1):5-9. doi: 10.17235/reed.2018.5490/2018.
35. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, De Silva P, Fuchs CS et al. Long-term Intake of Dietary Fat and Risk of Ulcerative Colitis and Crohn’s Disease. Gut 2014;63(5):776–784. doi:10.1136/gutjnl-2013-305304.